Vaccines

08 Nov 2016 DBV Technologies Completes Enrollment of Phase II Study of Viaskin Milk for the Treatment of Milk Allergic Patients
08 Nov 2016 GeoVax and ViaMune to Collaborate on Cancer Immunotherapy Program
07 Nov 2016 CryoVax(R) : Next Generation Immunotherapy for Metastatic Colorectal Cancer Begins USA Phase IIb Clinical Trial
07 Nov 2016 Neovacs enrolls the first U.S. Patient in Phase IIb study of IFNa Kinoid for treatment of Systemic Lupus Erythematosus (SLE)
07 Nov 2016 Mucosis Initiates First-in-Human Study of SynGEM®, a Needle-Free Nasal Spray RSV Vaccine
04 Nov 2016 ARTES and BioSun Announce Co-Development for HPV Vaccine
28 Oct 2016 Opiant Pharmaceuticals, Inc. Licenses Heroin Vaccine From Walter Reed Army Institute of Research and National Institute on Drug Abuse
28 Oct 2016 Data from Phase 1 Trial of Triplex Vaccine for Control of Cytomegalovirus Published in Blood
27 Oct 2016 Sanofi Pasteur, Fiocruz, and WRAIR Agree to Collaborate on Zika Vaccine Research
26 Oct 2016 PharmaJet® and Vaccibody collaborate on HPV vaccine development
25 Oct 2016 Topline Results from Two-Year Follow-Up Study of Viaskin Peanut Show Long-Lasting and High Levels of Desensitization to Peanut
25 Oct 2016 GSK announces US regulatory submission of candidate vaccine for prevention of shingles
24 Oct 2016 Inovio Announces FDA Request for Additional Information For Phase III Program; Trial Initiation Delayed
24 Oct 2016 Aduro Biotech Reports Partial Clinical Hold to Pause Enrollment in LADD Trials
20 Oct 2016 Pfizer Awarded Grant to Evaluate Vaccine to Protect Newborns Against Group B Streptococcus Infection
19 Oct 2016 Canadian Ebola vaccine enters new trial phase
17 Oct 2016 First Patient Randomized in Multiple Dose Cohort of Phase 1/1b Trial with Transgene’s TG1050 in Chronic Hepatitis B Patients
17 Oct 2016 Hookipa Secures EUR 4.16 Million Additional Grant Support from the Austrian Research Promotion Agency (FFG) to Develop Arenavirus Vector-Based Cancer Immunotherapies
13 Oct 2016 Immunovaccine Announces Positive Phase 1 Topline Data for DepoVax(TM)-based Respiratory Syncytial Virus Vaccine Candidate
13 Oct 2016 SELLAS™ Life Sciences Announces Positive Interim Phase II Results from its WT1 Immunotherapeutic Anti-cancer Treatment in Multiple Myeloma Patients
11 Oct 2016 Positive Preclinical Data for Immunovaccine's DepoVax(TM)-based Malarial Vaccine Presented at 2016 World Vaccine Congress Europe
11 Oct 2016 VBI Vaccines Completes Pre-IND Meeting for its Glioblastoma Immunotherapy Candidate
10 Oct 2016 Allergy Therapeutics presents enhanced efficacy data in a malaria vaccine model with its novel adjuvant system
29 Sep 2016 Genocea’s Genital Herpes Immunotherapy GEN-003 Demonstrates Significant Reduction of Viral Shedding in Phase 2b Clinical Trial
28 Sep 2016 Immune Design Announces Advancement of First GLAAS™-based Allergy Program into Clinical Development

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top